Abstract：
Functional precision medicine (FPM) has emerged as a new approach to improve cancer treatment. Despite its potential, FPM assays present important limitations such as the number of cells and trained personnel required. To overcome these impediments, here we describe a novel microfluidic platform that can be used to perform FPM assays, optimizing the use of primary cancer cells and simplifying the process by using microfluidics to automatize the process.
摘要：
功能精准医学（FPM）已成为改善癌症治疗的新方法。尽管有潜力,FPM测定存在重要的限制,例如所需的细胞数量和受过训练的人员。为了克服这些障碍，在这里，我们描述了一种可用于执行FPM测定的新型微流体平台，优化原发性癌细胞的使用，并通过使用微流体使过程自动化来简化过程。
